Cyclin-Dependent Kinase Inhibitors in the Rare Subtypes of Melanoma Therapy

被引:1
作者
Kaszubski, Jonatan [1 ]
Gagat, Maciej [2 ,3 ]
Grzanka, Alina [2 ]
Wawrzyniak, Agata [4 ]
Niklinska, Wieslawa [5 ]
Lapot, Magdalena [3 ]
Zuryn, Agnieszka [2 ]
机构
[1] Nicolaus Copernicus Univ Torun, Fac Med, Dept Histol & Embryol, Coll Medicum Bydgoszcz,Vasc Biol Student Res Club, PL-85067 Bydgoszcz, Poland
[2] Nicolaus Copernicus Univ Torun, Fac Med, Dept Histol & Embryol, Coll Med Bydgoszcz, PL-85067 Bydgoszcz, Poland
[3] Mazovian Acad Plock, Fac Med, Coll Med, PL-09402 Plock, Poland
[4] Univ Rzeszow, Inst Med Sci, Coll Med Sci, Dept Histol & Embryol, PL-35310 Rzeszow, Poland
[5] Med Univ Bialystok, Dept Histol & Embryol, PL-15269 Bialystok, Poland
关键词
melanoma; rare subtypes of melanoma; mucosal melanoma; uveal melanoma; acral melanoma; cyclin-dependent kinases (CDKs); CDK inhibitors (CDKIs); CDK4/6; CDK7/9; CDK2; ACRAL MELANOMA; UVEAL MELANOMA; DESMOPLASTIC MELANOMA; GENETIC ABERRATIONS; P16; EXPRESSION; MAPK PATHWAY; DISTINCT; CANCER; COMBINATION; PROTEINS;
D O I
10.3390/molecules29225239
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Melanoma occurs in various forms and body areas, not only in the cutis, but also in mucous membranes and the uvea. Rarer subtypes of that cancer differ in genomic aberrations, which cause their minor sensibility to regular cutaneous melanoma therapies. Therefore, it is essential to discover new strategies for treating rare forms of melanoma. In recent years, interest in applying CDK inhibitors (CDKIs) in cancer therapy has grown, as they are able to arrest the cell cycle and inhibit cell proliferation. Current studies highlight selective CDK4/6 inhibitors, like palbociclib or abemaciclib, as a very promising therapeutic option, since they were accepted by the FDA for advanced breast cancer treatment. However, cells of every subtype of melanoma do not react to CDKIs the same way, which is partly because of the genetic differences between them. Herein, we discuss the past and current research relevant to targeting various CDKs in mucosal, uveal and acral melanomas. We also briefly describe the issue of amelanotic and desmoplastic types of melanoma and the need to do more research to discover cell cycle dysregulations, which cause the growth of the mentioned forms of cancer.
引用
收藏
页数:18
相关论文
共 83 条
[1]   Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition [J].
Abdel-Rahman, Mohamed H. ;
Pilarski, Robert ;
Massengill, James B. ;
Christopher, Benjamin N. ;
Noss, Ryan ;
Davidorf, Frederick H. .
MELANOMA RESEARCH, 2011, 21 (03) :175-179
[2]   Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease [J].
Basurto-Lozada, Patricia ;
Molina-Aguilar, Christian ;
Castaneda-Garcia, Carolina ;
Estefania Vazquez-Cruz, Martha ;
Isaac Garcia-Salinas, Omar ;
Alvarez-Cano, Alethia ;
Martinez-Said, Hector ;
Roldan-Marin, Rodrigo ;
Adams, David J. ;
Possik, Patricia A. ;
Daniela Robles-Espinoza, Carla .
PIGMENT CELL & MELANOMA RESEARCH, 2021, 34 (01) :59-71
[3]   Immunohistochemical expression of p16 in desmoplastic melanoma [J].
Blokhin, Elena ;
Pulitzer, Melissa ;
Busam, Klaus J. .
JOURNAL OF CUTANEOUS PATHOLOGY, 2013, 40 (09) :796-800
[4]   Uveal melanoma diagnosis and current treatment options (Review) [J].
Branisteanu, Daniel Constantin ;
Bogdanici, Camelia Margareta ;
Branisteanu, Daciana Elena ;
Maranduca, Minela Aida ;
Zemba, Mihail ;
Balta, Florian ;
Branisteanu, Catalina Ioana ;
Moraru, Andreea Dana .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (06)
[5]   Melanocytic lesions - Staying out of trouble [J].
Brenn, Thomas .
ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 37 :91-102
[6]   Systematic review and meta-analysis of genomic alterations in acral melanoma [J].
Broit, Natasa ;
Johansson, Peter A. ;
Rodgers, Chloe B. ;
Walpole, Sebastian T. ;
Hayward, Nicholas K. ;
Pritchard, Antonia L. .
PIGMENT CELL & MELANOMA RESEARCH, 2022, 35 (03) :369-386
[7]   Contribution of CDKN2A/P16 INK4A, P14 ARF, CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma [J].
Buecher, B. ;
Gauthier-Villars, M. ;
Desjardins, L. ;
Lumbroso-Le Rouic, L. ;
Levy, C. ;
De Pauw, A. ;
Bombled, J. ;
Tirapo, C. ;
Houdayer, C. ;
Bressac-de Paillerets, B. ;
Stoppa-Lyonnet, D. .
FAMILIAL CANCER, 2010, 9 (04) :663-667
[8]   Acral melanoma: new insights into the immune and genomic landscape [J].
Carvalho, Larissa Anastacio DaCosta ;
Aguiar, Flavia C. ;
Smalley, Keiran S. M. ;
Possik, Patricia A. .
NEOPLASIA, 2023, 46
[9]   G1 phase arrest by the phosphatidylinositol 3-kinase inhibitor LY 294002 is correlated to up-regulation of p27Kip1 and inhibition of G1 CDKs in choroidal melanoma cells [J].
Casagrande, F ;
Bacqueville, D ;
Pillaire, MJ ;
Malecaze, F ;
Manenti, S ;
Breton-Douillon, M ;
Darbon, JM .
FEBS LETTERS, 1998, 422 (03) :385-390
[10]   p21CIP1 is dispensable for the G2 arrest caused by genistein in human melanoma cells [J].
Casagrande, F ;
Darbon, JM .
EXPERIMENTAL CELL RESEARCH, 2000, 258 (01) :101-108